<DOC>
	<DOCNO>NCT01388153</DOCNO>
	<brief_summary>To establish bioequivalence Glucobay ODT ( Orally Disintegrating Tablet ) take without water Glucobay standard tablet take water</brief_summary>
	<brief_title>A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet ( ODT ) Glucobay Standard Tablet</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>The informed consent must sign study specific test procedures do Healthy male subject Age : 18 45 year ( inclusive ) first screen examination / visit Ethnicity : White Body mass index ( BMI ) : above/equal 18 below/equal 28 kg / m² Confirmation subject 's health insurance coverage prior first screen examination / visit Ability understand follow studyrelated instruction Incompletely cure preexisting disease assume absorption , distribution , metabolism , elimination effect study drug normal Subjects medical disorder , condition history would impair subject 's ability participate complete study opinion investigator sponsor Known hypersensitivity study drug ( active substance excipients preparation ) Known severe allergy , nonallergic drug reaction , multiple drug allergy Chronic intestinal disorder associate distinct disturbance digestion absorption States may deteriorate result increase gas formation intestine ( e.g . Roemheld´s syndrome , major hernia , intestinal obstruction , intestinal ulcer , Crohn´s disease , ulcerative colitis , malabsorption ) Fasting blood glucose level outside normal range Impaired glucose tolerance glucose tolerance test</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Bioequivalence , acarbose , ODT</keyword>
</DOC>